2,3-Dihydro-2-benzyl-5-(2-nitrobenzyl)-1,5-benzothiazepin-4(5H)-one

ID: ALA2334795

PubChem CID: 71578377

Max Phase: Preclinical

Molecular Formula: C23H20N2O3S

Molecular Weight: 404.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]

Standard InChI:  InChI=1S/C23H20N2O3S/c26-23-15-19(14-17-8-2-1-3-9-17)29-22-13-7-6-12-21(22)24(23)16-18-10-4-5-11-20(18)25(27)28/h1-13,19H,14-16H2

Standard InChI Key:  JWGACCWJXAJASM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   10.4869  -17.7113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3049  -17.7355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7330  -17.0403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3443  -16.3205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5231  -16.3002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0987  -16.9961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9954  -18.0236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9943  -18.8431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7023  -19.2521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7006  -17.6147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4084  -18.8423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4092  -18.0200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0552  -17.5021    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.0568  -19.3574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8613  -17.6796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8628  -19.1712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2177  -18.4242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3749  -19.8081    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0512  -20.1746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3408  -20.5784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6373  -20.1611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9273  -20.5642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9213  -21.3823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6313  -21.7955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3383  -21.3900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2824  -16.9793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0460  -21.8010    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7549  -21.3945    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0436  -22.6181    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 11  2  0
 12 10  2  0
 10  7  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 16 17  1  0
 16 18  2  0
 14 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 15 26  1  0
 26  6  1  0
 27 28  2  0
 27 29  1  0
 25 27  1  0
M  CHG  2  27   1  29  -1
M  END

Associated Targets(Human)

MST1R Tchem Macrophage-stimulating protein receptor (2327 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHA2 Tclin Ephrin type-A receptor 2 (3499 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB4 Tclin Receptor protein-tyrosine kinase erbB-4 (2748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 (6262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCA Tchem Protein kinase C alpha (5923 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK2B Tbio Casein kinase II (1406 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1/cyclin B1 (1887 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 404.49Molecular Weight (Monoisotopic): 404.1195AlogP: 5.24#Rotatable Bonds: 5
Polar Surface Area: 63.45Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.17CX LogD: 5.17
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.43Np Likeness Score: -1.01

References

1. Zhang P, Hu HR, Bian SH, Huang ZH, Chu Y, Ye DY..  (2013)  Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).,  61  [PMID:23047001] [10.1016/j.ejmech.2012.09.021]

Source